Georgetown Lombardi Comprehensive Cancer Center | Strategic Alliance Partners

home / sap-partners / cancer-centers / georgetown-lombardi

Latest from Georgetown Lombardi Comprehensive Cancer Center

Investigators Identify Immunotherapy Followed by BRAK/MEK Inhibition as Optimal Sequence Strategy in BRAF+ Melanoma

October 11th 2022

Optimal treatment sequencing for patients with BRAF-mutated melanoma involves frontline immunotherapy following by BRAF/MEK inhibition, according to investigators.

Guiding Nurses On HCC Management During The Era Of COVID-19

Staff

May 21st 2020

This OncLive® webinar focused on the impact of COVID-19 on oncology nursing care for patients with hepatocellular carcinoma. We featured oncology nurse experts, Amy Hillsman, CRNP, and Abigail Smith, CRNP, discussing important topics and considerations for nurses and how they continue to provide the best care for their patients during this time.